<DOC>
	<DOCNO>NCT01956799</DOCNO>
	<brief_summary>The study aim evaluate molecular mechanism underlie erythroid response observe patient myelodysplasia , myelofibrosis aplastic anemia treat Deferasirox Deferoxamina .</brief_summary>
	<brief_title>Identification Mechanism Erythroid Response Patients With Myelodysplasia Undergoing Chelation Therapy</brief_title>
	<detailed_description />
	<mesh_term>Primary Myelofibrosis</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>1 . Patients age 18 old 2 . Diagnosis Myelodysplasia , myelofibrosis aplastic anemia 3. transfusiondependent anemia undergo chelation therapy deferasirox deferoxamine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>MDS</keyword>
	<keyword>PMF</keyword>
	<keyword>CMML</keyword>
	<keyword>AA</keyword>
</DOC>